rviewarticle echinacea in three main · 2019. 7. 30. · rviewarticle self-care for common colds:...
TRANSCRIPT
-
Review ArticleSelf-Care for Common Colds: The Pivotal Role ofVitamin D, Vitamin C, Zinc, and Echinacea in Three MainImmune Interactive Clusters (Physical Barriers, Innate andAdaptive Immunity) Involved during an Episode of CommonColds—Practical Advice on Dosages and on the Time to TakeThese Nutrients/Botanicals in order to Prevent or TreatCommon Colds
Mariangela Rondanelli ,1 Alessandra Miccono,1 Silvia Lamburghini,1
Ilaria Avanzato,1 Antonella Riva ,2 Pietro Allegrini,2 Milena Anna Faliva,1
Gabriella Peroni,1 Mara Nichetti,1 and Simone Perna 1
1Department of Applied Health Sciences, Azienda di Servizi alla Persona (ASP) di Pavia, University of Pavia, Pavia, Italy2Research and Development Unit, Indena, Milan, Italy
Correspondence should be addressed to Simone Perna; [email protected]
Received 20 November 2017; Revised 6 March 2018; Accepted 26 March 2018; Published 29 April 2018
Academic Editor: Roland Schoop
Copyright © 2018 Mariangela Rondanelli et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.
Maintaining a normal healthy immune defense system lowers the incidence and/or the severity of symptoms and/or the durationof common cold (CC). Physical barriers and innate and adaptive immunity have been involved during a CC episode. Vitamins Cand D, zinc, and Echinacea have evidence-based efficacy on these immune system barriers. This review includes 82 eligible studiesto consider the preventive role of these nutrients in immune clusters and in CC to provide advice on dosage and assumption ofthese nutrients. Regarding vitamin C, regular supplementation (1 to 2 g/day) has shown that vitamin C reduces the duration (inadults by 8%, in children by 14%) and the severity of CC. Considering zinc, the supplementation may shorten the duration ofcolds by approximately 33%. CC patients may be instructed to try zinc within 24 hours of onset of symptoms. As for vitamin D, thesupplementation protected against CC overall, considering baseline levels and age. Patients with vitaminD deficiency and those notreceiving bolus doses experienced the most benefit. Regarding Echinacea, prophylactic treatment with this extract (2400mg/day)over 4months appeared to be beneficial for preventing/treatingCC. In conclusion, the current evidence of efficacy for zinc, vitaminsD and C, and Echinacea is so interesting that CC patients may be encouraged to try them for preventing/treating their colds,although further studies are needed on this topic.
1. IntroductionCommon cold (CC) is a conventional term used for mildupper respiratory illnesses, which comprises a heterogeneousgroup of self-limited diseases caused by numerous virusesand is the most frequently encountered human diseasesworldwide [1].
In European populations, adults have from 2 to 5 infec-tions annually, children typically present 6 to 12 “colds” peryear, and rates of symptomatic infections increase in theelderly [2]. A seasonal variation is present withmore episodesin winter and fall [1] and, on average, episodes of commoncolds last around 10 days [3].
HindawiEvidence-Based Complementary and Alternative MedicineVolume 2018, Article ID 5813095, 36 pageshttps://doi.org/10.1155/2018/5813095
http://orcid.org/0000-0001-8336-4851http://orcid.org/0000-0003-2819-943Xhttp://orcid.org/0000-0002-2720-1473https://doi.org/10.1155/2018/5813095
-
2 Evidence-Based Complementary and Alternative Medicine
Beyond impairing the quality of life [4], common coldshave a tremendous economic burden on societies due toworkabsenteeism [5, 6].
Thus, treatments that reduce the incidence of infectionand/or lessen the severity of symptoms and/or shorten theduration of common colds are of high interest both for theindividual and for the whole society.
Maintaining the immune defense systemwithin a normalhealthy state lowers the incidence of infection and/or lessensthe severity of symptoms and/or shortens the duration ofcommon colds. Natural killer cell (NK cell) activity andsalivary immunoglobulin A (IgA) are considered importantin the prevention of common colds [7]. However, severalenvironmental factors, including a stressful lifestyle, are likelyto weaken the immune defense system [8], which mayresult in an increased risk of common cold. Lifestyles andmental health status are associated with natural killer cell andlymphokine-activated killer cell activities [8]. The immunesystem is an intricate network of specialized tissues, organs,cells, and chemicals protecting the host from infectiousagents and other noxious insults. Although these defensemechanisms are very complex, they can be described as beingorganized in threemain interactive clusters: physical barriers,and innate and adaptive immunity [9, 10].
The first barrier against “invaders” consists of physicalbarriers (low pH caused by various fatty acids and enzymes;it can limit the growth of most bacteria), mucus secretion (itcontains proteins that can destroy pathogens), and the acidityof the stomach. Innate immunity is the second barrier andincludes immune system cells, such as NK cells, cytokines(such as interferon-𝛾), macrophages, and neutrophil granu-locytes. In addition, zinc shows its antiviral effects throughthe Intercellular Adhesion Molecule 1 (ICAM-1). Adaptiveimmunity is the third barrier to infection and is acquiredlater in life, such as after an immunization or successfullyfighting off an infection. It retains a memory of all theinvaders it has faced and this accelerates antibody production[11]. It includes lymphocytes T (e.g., regulatory T cells) andlymphocytes B.
1.1. Mechanism of Innate Immunity (Physical Barriers andImmune Cells) during Common Cold. When a respiratoryvirus is inhaled it first binds to nonspecific receptors on therespiratory epithelium, usually glycolipids or glycoproteins.Membrane fusion or endocytosis follows, thus internalizingthe virus and enabling subsequent replication, transcription,and translation of new viruses which can then be releasedto infect new cells. Once a cell has been infected, pathogen-associated molecular patterns (PAMPs) on the virus canbe recognized by various intracellular innate pathogenrecognition receptors (PRRs) such as the toll-like receptors(TLRs), retinoic-acid-inducible gene-I- (RIG-I-) like recep-tors (RLRs), and nucleotide binding-oligomerization domain(NOD-) like receptors (NLRs) [12]. Pulmonary epithelialcells have been shown to express all of the known humanTLRs and RLRs that detect viruses, and ligands for thesePRRs activate epithelial cells in order to initiate a rapidimmune response against viral invasion [13]. In addition to
direct infection of epithelial cells, intraepithelial dendriticcells (DCs) residing just below the respiratory epithelium andtissue-resident macrophages continually sample particles inthe airway lumen and can internalize them by phagocytosisandmacropinocytosis, thus activating PRRs and initiating animmune response [14, 15].
Features of the induced antiviral state include resistanceto viral replication in all cells, induction of apoptotic celldeath in infected cells, increased major histocompatibil-ity complex (MHC) class I expression to enhance anti-gen presentation, activation of dendritic cells (DCs) andmacrophages, and stimulation of natural killer (NK) cellsto enhance their cytolytic activity [16]. The inflammatorycytokines TNF-𝛼, IL-1𝛽, IL-6, and IL-12 are also producedat an early stage of the innate immune response. Thesecytokines promote leukocyte extravasation by increasingendothelial expression of adhesion molecules increasing vas-cular permeability, induce synthesis of acute phase proteins,and contribute to recruitment and activation of cells of theadaptive immune response [12]. Other antimicrobial vitaminD dependent peptides, such as cathelicidins and defensins,are involved in the second barrier.
1.2. Mechanism of Adaptive Immunity (Antibodies) dur-ing Common Cold. Around 72 h after infection, DCs withantigen-MHC complexes migrate through the afferent lymphvessels to secondary lymph nodes where they form inter-actions with naive CD4 and CD8 T lymphocytes. TheseT lymphocytes activate, proliferate, and differentiate intoeffector T cells and migrate via efferent lymph vessels intothe circulation. Multiple chemokines are expressed in therespiratory epithelium and result in changes in integrinaffinity, allowing effector T cells to bind to the endotheliumand migrate into the infected tissue [17–19]. For efficientand effective viral clearance Th1 effector T cells are required,which produce IL-2, TNF-𝛼, and IFN-𝛾 to activate NK cellsand induce generation of cytolytic molecules. CD8 effector Tcells and NK cells can then induce apoptosis of infected cells[17]. B cells have also been demonstrated to play an importantrole in the immune response to highly pathogenic viralinfections. Contact between CD4 T cells and naive B cellsin secondary lymphoid tissues results in their proliferationand antibody class-switching, with neutralizing virus-specificantibodies crucial for optimal viral clearance. Additionally,viral components expressed on infected cells allow antibodiesto bind, thus initiating antibody-dependent cell-mediatedcytotoxicity (ADCC), whereby CD16 on NK cells recognizesthe Fc portion of antibodies bound to the surface and kills thetarget cell [12, 17, 20, 21].
1.3. Self-Care for Common Colds: Role of Nutrition and Botan-icals and Their Interaction in Three Main Immune InteractiveClusters: Physical Barriers, Innate and Adaptive Immunity. Ascommon colds have a self-limited course and resolve withouttreatment, studies on self-care have shown that commoncolds are the most frequent cause for self-care [22–24]. Avariety of alternative and nonpharmacologic treatments ofthe common cold are proposed [25, 26]. Between these
-
Evidence-Based Complementary and Alternative Medicine 3
numerous nonpharmacological approaches for preventionand treatment of the common cold, there are the intakesof some nutrients, such as zinc, selenium, iron, copper, b-carotene, vitamins A, D, C, and E, folic acid, and botanicals,such as Echinacea [26]. The proposed biologic mechanismsare that these nutrients can significantly influence severalcomponents of immunity [10]. But among these numerousnutrients, which have proven to have evidence-based efficacyon all three immune system barriers? The nutrients arevitamin C, vitamin D, and zinc, because all three nutrientshave specific EFSA (European Food Safety Authority) scien-tific opinion on the substantiation of health claims relatedto vitamin D [27], vitamin C [28], zinc [29], and normalfunction of the immune system. Moreover, there is EFSAscientific opinion on the substantiation of health claimsrelated to zinc [30] and to vitamin C [31] and maintenance ofnormal physical barriers, the first immune system barriers.Finally, for vitamin C [32] and Echinacea [33] there areCochrane reviews regarding the use of these two nutrients forpreventing and treating the common cold.
Given this background, the purpose of this narrativereview is to consider the pivotal role of vitamin D, vitaminC, zinc, and Echinacea on three main immune interactiveclusters (physical barriers, innate and adaptive immunity) interms of prevention and treatment (shortening the durationand/or lessening the severity of symptoms) of common coldsin order to provide practice advice on the dosages and on thetime to take these nutrients.
2. Methods
The present systematic review was performed following thesteps by Egger et al. as follows [34]: (1) A working group wasconfigured as follows : three operators skilled in endocrinol-ogy and clinical nutrition, of whom one acting as a method-ological operator and two participating as clinical operators.(2)The revision question on the basis of considerations madein the abstract was formulated as follows: “the state of the arton role of vitamin D, vitamin C, zinc, and Echinacea in threemain immune clusters (physical barriers, innate and adaptiveimmunity) in terms of prevention and treatment (shorteningthe duration and/or lessening the severity of symptoms)of common colds.” (3) Relevant studies were identifiedas follows: a research strategy was planned, on PubMed[PublicMedline run by the National Center of BiotechnologyInformation (NCBI) of the National Library of Medicine ofBethesda (USA)], as follows: (a) definition of the key words(common cold, Echinacea, immunity, nutrients, vitamin C,vitamin D, and zinc), allowing the definition of the interestfield of the documents to be searched, grouped in quotationmarks (“. . .”), and used separately or in combination; (b) useof the Boolean AND operator that allows the establishmentof logical relations among concepts; (c) research modalities:advanced search; (d) limits: time limits: papers publishedin the last 30 years; languages: English; (e) manual searchperformed by the senior researchers experienced in clinicalnutrition through revision of reviews and individual articleson role of vitamin D, vitamin C, zinc, and Echinacea in three
main immune interactive clusters (physical barriers, innateand adaptive immunity) in terms of prevention and treatment(shortening the duration and/or lessening the severity ofsymptoms) of common colds published in journals qualifiedin the Index Medicus. (4) The analysis was carried out in theform of a narrative review of the reports.
3. Results
3.1. Zinc and the Three Main Immune Interactive Clusters(Physical Barriers, Innate and Adaptive Immunity) Involvedduring an Episode of Common Colds. This research has beencarried out based on the following keywords: “zinc” OR “zincsupplementation” AND “immune response” AND “innateimmunity” AND “adaptive immunity” AND “respiratorytract infections” AND “common cold” AND “Immunodefi-ciency.”
Figure 1 shows the study selection process.Table 1 summarizes the studies presented in the narrative
review.
3.1.1. First Barrier: Physical Barrier. In the present era,approximately two billion people in developing countriessuffer from Zn deficiency (ZnD), mainly due to malnutritionand manifest clinical characteristics of growth retardationand compromised immune systems [35].
Adequate zinc intake helps to maintain physical barriersand mucosal membrane integrity and unbound zinc ionsexert a direct antiviral effect on rhinovirus replication [10].Supplementation of Zn improves immune functions, includ-ing delayed cutaneous hypersensitivity in children (10–20mgof Zn) [36, 37], but other authors do not completely agree[38, 39]. It improves delayed-type hypersensitivity (DTH) inchildren supplemented with 10mg/day [40].
3.1.2. Second Barrier: Cellular Natural Immunity. Zinc sup-plementation increases cellular components of innate immu-nity (e.g., phagocytosis by macrophages and neutrophils,natural killer cell activity, and generation of oxidative burst)[10].
(1) Neutrophil granulocytes, macrophages: largeamounts of oral zinc significantly impaired polymor-phonuclear leukocytes (PMNL) function and, invitro, zinc potentiated the neutrophil response againstStaphylococcus aureus [11]. Zn supplementation(150mg/d) in elderly also induces a decrease in gran-ulocyte zinc that has implications in phagocytosisand chemotaxis [41].
(2) Natural killer: a supplementation of zinc (in vitrostudies or 100mg/d in elderly) improves natural killer(NK) cells activity, as argued by a lot of authors [9,11, 39, 42]. Zinc administration decreased peripheralblood NK cell activity in vitro in patients with thatinflammatory disease [11].
(3) Cytokine: common cold viruses increase oxidativestress, which activates macrophages and mono-cytes and results in increased production of both
-
4 Evidence-Based Complementary and Alternative Medicine
Table1:Stud
ieso
nzinc,immun
ity,and
common
cold
presentedin
then
arrativ
ereview.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Turner;2001
Clinicalstu
dy,
rand
omized
Ninety-on
evolunteers
41tre
ated
with
activ
emedication
(con
sistedof
33mM
zinc
glucon
ate)and
50tre
ated
with
placebofor3
days
were
inoculated
with
rhinoviru
sand
then
were
treated
with
study
medicationfora
nadditio
nal6
days,singlen
asalsprayof
120m
Lpern
ostril,at∼4-hintervals,5
times
each
day
Zinc
treatmenth
adno
effecto
ntotalsym
ptom
score,rhinorrhea,
nasalobstructio
n,or
thep
ropo
rtion
ofinfected
volunteerswho
developedclinicalcolds
Mahalanabis
etal.;2004
Rand
omized,
doub
le-blin
d,placebo-
controlled
clinicaltria
l
153child
ren
aged
2–24
Four
treatment:(1)zinca
cetate(10m
gelem
entalZ
ntwiced
ailyfor5
d)plus
aplaceboforv
itamin
A,(2)
vitamin
Aas
retin
ylpalm
itate[10,000𝜇
gretin
olequivalents(RE
)twiced
ailyfor4
d]plus
aplacebo
forz
inc,(3)zincp
lusv
itamin
Aaccordingto
thea
bove
schedu
le,or
(4)
placeboforz
inca
ndforv
itamin
A
Zinc
treatmentsignificantly
redu
ces
duratio
nof
fevera
ndvery
illsta
tus
inbo
ys,but
notingirls,w
ithsevere
acutelow
errespira
tory
infection
(ALR
I)
Zinc
asam
icronu
trient
playsa
keyroleat
thec
atalyticsites
ofaw
ider
ange
ofenzymes
andiscriticaltohu
man
grow
th,
metabolism
,and
immun
efun
ction.
The
dietso
fchildrenin
manydeveloping
coun
triesa
reoft
endeficient
inzinc
anda
high
phytate:zinc
ratio
intheird
iet
redu
cesz
incb
ioavailability
Barnettetal.;
2016
Arand
omized
doub
le-blin
d,placebo-
controlled
trial
53nu
rsingho
me
elderly(aged
≥65
y)
Supp
lementatio
nwith
30mgZn
/dfor
3mo
Theincreaseinserum
zinc
concentrationisassociated
with
the
enhancem
ent
ofTcellfunctio
n
Adaptiv
eim
mun
ity
Mainlybecauseo
fanincrease
inthe
numbero
fTcells
andZn
improves
Tcell-mediatedfunctio
nby
increasin
gthe
numbero
ffun
ctionalT
cells
inthe
perip
hery
Prasad
etal.;
2007
Rand
omized,
doub
le-blin
d,placebo-
controlled
trial
Fifty
healthy
subjectsof
both
sexesa
ged
55–87y
Each
dayfor12mo,subjectsin
the
zinc-sup
plem
entedgrou
preceived
1capsuleo
fzincg
luconate(15m
gelem
entalzinc)orally
Them
eanincidenceo
finfectio
nspersub
jectin
12mowas
significantly
lower
inthe
zinc-sup
plem
entedgrou
pthan
inthep
lacebo
grou
p.Asig
nificantly
lower
incidenceo
ffever
anda
nonsignificanttrend
towardalow
erincidenceo
fthe
common
cold
were
observed
inthez
inc-supp
lemented
grou
pthan
inthep
lacebo
grou
p
Innate
immun
ity
Zinc
supp
lementatio
ndecreasedno
tonly
thep
rodu
ctionof
inflammatory
cytokinesb
utalso
thatof
oxidatives
tress
marker:theincreaseo
fIL-2prod
uctio
nin
zinc-deficientelderlysubjectsby
increasin
gtheg
enee
xpressionof
IL-2
andby
adecreaseinIL-10prod
uctio
n
Pinn
aetal.;
2002
Clinicalstu
dy8healthymen
Thes
ubjectsw
ereg
iven
acon
trolled3-d
rotatin
gdietthatcontained4.6m
gZn
/d.
Znintakesw
erea
djustedby
giving
Znglucon
ates
upplem
ents.
Duringbaselin
eperio
dsandrepletionperio
ds,sub
jects’
Znintakestotaled
13.7mg/d.During
restric
tionperio
d,thes
ubjectsc
onsumed
4.6m
gof
high
lyavailableZ
n
Changesinlymph
ocyte
proliferatio
nandIL-2Rexpressio
nmay
beearly
markersof
mild
zinc
deficiency
Innate
immun
ity
Zinc
restr
ictio
nredu
cedperip
heralblood
mon
onuclear
cells
(PBM
NC)
proliferatio
natallm
itogen
concentrations
teste
dexcept
10mg/L.
Dietary
zinc
restric
tionredu
cedIL-2R
secretionby
PBMNCstim
ulated
ata
subo
ptim
alPH
Aconcentration.
Thes
ecretio
nof
IFN-𝛾
andTN
F-𝛼was
unchangedthroug
hout
thes
tudy
-
Evidence-Based Complementary and Alternative Medicine 5
Table1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Maggini
etal.;2012
Datafrom
two
prelim
inary,
doub
le-blin
d,rand
omized,
placebo-
controlledtrials,
parallel-g
roup
Stud
y1included
30patie
nts:13
males
and17
females
Stud
y2enrolled
64patie
nts:25
males
and39
females
1000
mgvitamin
Cplus
10mgzinc
Supp
lementatio
nwith
vitamin
Candzinc
may
representan
efficaciou
smeasure
Prasad
etal.;
2008
Rand
omized,
doub
le-blin
d,placebo-
controlled
trial
Fifty
ambu
latory
volunteerswere
recruitedwith
in24
hof
developing
symptom
softhe
common
cold
1lozenge
containing
13.3mgof
zinc
(as
zinc
acetate)or
placeboevery2-3h
while
beingaw
ake
Meandu
ratio
nsof
cold
symptom
s,coug
h,nasald
ischarge,andmuscle
ache
weres
ignificantly
decreasedin
thez
incg
roup
comparedwith
the
placebogrou
pthanks
toits
anti-inflammatoryandantio
xidant
prop
ertie
s
Innate
immun
ity
Thed
ecreaseinsIL-1raa
ndsTNF-R1
levelsin
thez
incg
roup
onlysuggeststhat
zinc
decreasedtheo
xidativ
estre
ss,
resulting
indecreasedactiv
ationof
mon
ocytes
andmacroph
ages
Zinc
decreasesICA
M-1levelsandindu
ces
thez
inc-depend
enttranscriptio
nfactor
A20
inmon
ocytes
andmacroph
ages,
which
inhibitsNF-kB
activ
ationviathe
TNF-R-associated
factor
pathway
Zinc
isan
inhibitoro
fNADPH
oxidase,
anenzymethatinitia
testhe
generatio
nof
freer
adicals;itisessentialfor
superoxide
dism
utasea
ndforg
enerationof
metallothionein,
redu
cedthec
oncentratio
nof
the
oxidatives
tressmarkers,and
inhibited
thee
xvivo
indu
ctionof
TNF-𝛼andIL-1𝛽
mRN
Ain
mon
onuclear
cells;and
itprovided
protectio
nagainst
TNF-𝛼-in
ducedNF-kB
activ
ationin
isolatedperip
heralblood
mon
onuclear
cells
Bhandariet
al.;2002
Dou
blem
asked,
rand
omized
placebo-
controlled
trial
2482
child
ren
aged
6to
30mon
ths
Dailyele
mentalzinc,10mgto
infantsa
nd20
mgto
olderc
hildrenor
placebofor
four
mon
ths.Zinc
glucon
ate
Zinc
supp
lementatio
nsubstantially
redu
cedtheincidence
ofpn
eumon
iain
child
renwho
had
received
vitamin
A
Skin
Innate
immun
ityandadaptiv
eim
mun
ity
Supp
lementatio
nim
proves
immun
efunctio
ns,including
delay
edcutaneou
shypersensitivity,and
increasesthe
numbero
fCD4(help
er)lym
phocytes
Inexperim
entalm
odelsz
incd
eficiency
hasb
eenshow
nto
impaircellu
lara
ndhu
moralim
mun
efun
ction
-
6 Evidence-Based Complementary and Alternative Medicine
Table1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Bogden
etal.;
1990
Dou
ble-blind
partialcrossover
desig
n
63subjects(age
60–89)
3–6mon
thsupp
lyof
placebo,15mgof
Zn,or100
mgZn
-capsules
Zinc
hadpo
sitivee
ffectso
non
emeasure
ofcellu
larimmun
efunctio
nbu
tatthe
sametim
ehad
anadversee
ffecton
another
measure
ofcellu
larimmun
ity
Innate
immun
ity
NKcellactiv
itywas
enhanced,but,except
forthisc
ellularimmun
efun
ctions,w
ere
notsignificantly
improved
Dela
yedderm
alhypersensitivity
(DDH)
increasedin
thes
tudy
inplacebogrou
pandthes
uppressio
nof
theincreasein
DDHby
zinc
persisted
McD
onaldet
al.;2015
Arand
omized,
doub
le-blin
d,placebo-
controlled
clinicaltria
l
2400
infants
who
were6
wk
ofagea
ndbo
rnto
HIV-negative
mothersin
alow-m
alaria
setting
,Tanzania
Oralsup
plem
entatio
nof
MVs(vitamin
Bcomplex
andvitaminsC
andE),zinc,
zinc
+MVs,or
placebofor18m
o.From
thetim
eofrando
mizationto
6mo
ofage,infantsreceived1capsule/d,and
from
7moof
agetothee
ndof
follo
w-up,
2capsules
werep
rovideddaily
The
capsulec
ontained
5mgof
zinc
Acuteu
pper
respira
tory
infections
weres
ignificantly
lower
forinfants
supp
lementedwith
zinc
than
for
thosew
hodidno
treceive
zinc
Adaptiv
eim
mun
ity
MeanCD
4Tcellpercentage
was
slightly
butsignificantly
high
eram
ongchild
ren
who
received
zinc
andMVsin
comparis
onwith
placebo
Isbaniah
etal.;2010
Dou
ble-blind,
rand
omized,
placebo-
controlled
trial
Chronic
obstr
uctiv
epu
lmon
ary
disease(CO
PD)
patie
ntsw
ithacuteu
pper
respira
tory
tract
infection
(URT
I)—108
mostly
male
patie
nts(age
40–81)
Treatm
ent:EP
(Echinacea
purpurea)o
rEP
+zinc,sele
nium
,and
ascorbicacid
orplacebozinc
=10mg
Thec
ombinatio
nof
EP—zinc,
selenium
,and
ascorbic
acid—alleviates
exacerbatio
nsymptom
scausedby
URT
Iin
COPD
Innateand
adaptiv
erespon
se
Itseem
sthatb
othselen
ium
andzinc
act
onTlymph
ocytes,throu
ghmod
ulating
IL-2
secretion,
itsreceptor
expressio
n,andsensitivity,asw
ellasthe
thym
ulin
activ
itywhich
isrequ
iredforthe
differentiatio
nof
CD4+
Tcells.
Zinc
isinclu
dedin
theb
iosynthesis
ofleuk
otrie
neB4
.Finally,the
transcrip
tionalrepressor
Gfi1,
azingerfi
nger
protein,
was
identifi
edas
aregulator
oftheinn
ateimmun
erespo
nse
andto
beessentialfor
thed
evelo
pmento
fmacroph
ages-dependent
cytokine
prod
uctio
nandgranulocytes
Fieldetal.;
1987
Clinicalstu
dy15
female
patie
nts
Zinc
supp
lements(50,100,150m
g)Ev
idence
inplasmaa
ndleucocyte
zinc
concentrations
inan
elderly
popu
latio
n
Innate
immun
ity
Decreaseingranulocytew
ithhigh
zinc
dosesp
robablythanks
tothed
iminish
edph
agocyticandchem
otactic
activ
ityof
polymorph
onuclear
cells
-
Evidence-Based Complementary and Alternative Medicine 7
Table1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Wintergerst
etal.;2005
Review
:alarge
numbero
frand
omized
controlled
interventio
ntrials
Hum
anDailyintakeso
f10–
30mgof
zinc
for
child
renwith
infectious
diseases
Thea
utho
rsexplainthatzinc
and
vitamin
Cplay
anim
portantrolein
immun
esystem:adequ
ateintakes
amelioratesymptom
sand
shorten
thed
urationof
respira
tory
tract
infection,
inclu
ding
thec
ommon
cold,but
therea
rediscrepanciesin
trialsthathave
been
considered
Innateand
adaptiv
eim
mun
ity
Zinc
isessentialfor
theintracellu
lar
bind
ingof
tyrosin
ekinasetoTcell
receptors,which
arer
equiredforT
lymph
ocyted
evelo
pmentand
activ
ation—
lowered
zinc
status
impairs
cellu
larm
ediatorsof
innateim
mun
itysuch
asph
agocytosisby
macroph
ages
and
neutroph
ils,naturalkillerc
ellactivity,
generatio
nof
theo
xidativ
eburst,
and
complem
entactivity
Sancheze
tal.;
2014
Rand
omized
triple-blin
dcommun
itytrial
301children,
2–5yearso
fage
Child
renwered
istrib
uted
inthreeg
roup
sreceivingzinc
aminoacid
chelate,zinc
sulfate,and
placebofived
aysa
weekfor
16weeks
7mgof
zinc
forc
hildrenwith
2-3years
and9,4
5mgof
zinc
forc
hildrenwith
4-5
years
Zinc
aminoacid
chelateh
adab
etter
effecto
nredu
cing
theincidence
ofacuter
espiratory
infectionin
child
ren
Innate
immun
ity
Prob
ablythanks
tothep
rodu
ctionof
interfe
ronandthem
odulationof
inflammatorycytokines
Martin
ez-
Esteveze
tal.;
2016
12-m
onth
rand
omized
controlledtrial,
triple-blin
d
355child
ren
underw
ent
rand
omization,
with
174
assig
nedto
the
zinc
supp
lemen-
tatio
ngrou
pand
181tothe
controlgroup
Child
renin
thea
ctives
upplem
entatio
ngrou
preceived
5mgof
zinc
oxidep
lus
525m
gof
calcium
carbon
atep
lus7
0UIo
fvitamin
D3(K
idCa
l),andchild
renin
the
nonsup
plem
entedcontrolgroup
received
525m
gof
calcium
carbon
atep
lus7
0UIo
fvitamin
D3
Decreased
theincidence
ofURT
IInnate
immun
ity
Amon
gthev
arious
mechanism
sinvolved
inthea
ntivira
leffectso
fzinc,theICA
M-1
receptor
blocking
hasb
eenconsidered
ason
eofthe
mostimpo
rtantactions
Broo
ksetal.;
2004
Dou
ble-blind
placebo-
controlled
trial
270child
ren
(age
2–23
mon
ths)
Elem
entalzinc,20
mgperd
ay,orp
lacebo
Zinc
acceleratesrecoveryfro
msevere
pneumon
iain
child
renand
couldhelpredu
ceantim
icrobial
resis
tanceb
ydecreasin
gmultip
leantib
iotic
expo
suresa
ndles
sen
complications
anddeaths
where
second
lined
rugs
areu
navailable
Innate
immun
ity
Zinc
hasroleinthea
cuteph
aser
espo
nse
mediatedby
cytokinesd
uringacute
infection,
helpingto
boostthe
body’s
immun
erespo
nsethrou
ghad
efense
cascade,beginn
ingwith
mob
ilizatio
nand
sequ
estrationof
zinc
tometallothionein-richtissue,rapid
upregulationof
immun
edefense
specific
proteinsynthesis
,activationof
immun
edefensea
ctivity
such
asmacroph
ages,
lymph
ocytes,and
NKcells
and
antib
ody-depend
entcytotoxicity
-
8 Evidence-Based Complementary and Alternative Medicine
Table1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Sazawaletal.;
1997
Ado
uble-blin
d,rand
omized
controlledtrial
Child
ren(zinc
38,con
trol48)
Zinc
glucon
atetoprovidee
lementalzinc
10mgdaily
and20
mgdu
ringdiarrhea
Zinc
supp
lementatio
nim
proves
cellu
larimmun
estatus:regarding
cell-mediatedim
mun
ity(C
MI),the
percentage
ofanergico
rhypoergic
child
ren(usin
gindu
ratio
nscore)
decreasedfro
m67%to
47%in
the
zinc
grou
p.Th
ezincg
roup
hadas
ignificantly
high
erris
eintheg
eometric
means
ofCD
3,CD
4,andCD
4/CD
8ratio
with
nodifferenceinCD
8and
CD20.Th
erise
inCD
4was
significantly
high
erin
thez
inca
scomparedto
thec
ontro
lgroup
Adaptiv
eim
mun
ity
Theo
bservatio
nof
anincrease
inthe
numbero
fcirc
ulatingTlymph
ocytes,
especiallyCD
4cells,afte
rzinc
supp
lementatio
nmay
beexplainedby
directeffecto
fzincion
onthelym
phocyte
mem
branea
ffectingmaturationand
differentiatio
nof
Tlymph
ocytes
orby
astim
ulationof
thym
usendo
crine
functio
n.OnceT
lymph
ocytes
leavethe
thym
ustheird
ifferentia
tionand
maturationaretho
ught
tobe
regu
latedby
zinc-th
ymulin
anddeficiencyof
zinc-th
ymulin
hasb
eenassociated
with
second
arycellu
larimmun
edeficiency
andwith
immun
esenescence.Th
usterm
inaldeoxynucleotidyltransfe
rase
orzinc-th
ymulin
hasb
eensuggestedas
possiblemechanism
bywhich
zinc
may
beaffectin
gTcelldevelopm
entand
functio
n
Sempertegui
etal.;1996
Arand
omized
doub
le-blin
dplacebo-
controlled
trial
50child
ren(age
12–59mon
ths
old)
10mgof
zinc
sulfateor
placebo
Afte
rtreatment(on
day60),the
cutaneou
sdelayed-ty
pehypersensitivity
(DTH
)was
high
erin
treated
grou
p;theincidence
offever,coug
h,andup
perrespiratory
tractssecretions
was
lower
inS
grou
p,bu
tafte
r120
days
the
incidenceo
ffever
andup
per
respira
tory
tractssecretions
was
the
sameinbo
thgrou
ps,but
the
incidenceo
fcou
ghwas
high
erin
Sgrou
p
Innate
immun
ityTh
emechanism
isno
tclear,probably
improvingcellu
larimmun
ity
Bogden
etal.;
1988
Clinicalstu
dy103eld
erly
subjects(age
60–89years)
Threetreatments:
placebo,or
15mg
zinc/day
or100m
g/dayfor3
mon
ths
Inas
ubgrou
p(34,3%
),Zn
administratio
nenhanced
delay
edderm
alhypersensitivity
(DDH)
Skin,inn
ate
immun
ity
cellu
larimmun
itywill
notb
eenh
anced
byZn
supp
lementatio
n,bu
ttheyargued
thatcellu
larimmun
ityin
subgroup
sof
elderly
peop
lewill
beim
proved
byZn
supp
lementatio
n
-
Evidence-Based Complementary and Alternative Medicine 9Ta
ble1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Fortes
etal.;
1998
Ado
uble-blin
d,rand
omized,
controlledtrial
178eld
erly
patie
nts
4tre
atments:
(1)v
it.A(800𝜇gretin
olpalm
itate),(2)zinc(25
mgas
zinc
sulfate),(3)zinc+
vit.A(800𝜇gretin
olpalm
itateand25
mgof
zinc
sulfate),(4)
placebo
Zinc
supp
lementatio
nim
proves
cell-mediatedim
mun
erespo
nse,
becauseitincreases
then
umbero
fCD
4+DR+
Tcells
andcytotoxicT
lymph
ocytes
Immun
eand
adaptiv
erespon
se
Effecto
nthym
ulin
levelsthatprom
otes
Tcells
functio
ns,including
supp
ressor
functio
nandinterle
ukin-2
prod
uctio
n.Zn
preventsthen
egativity
effectsof
vit.A
onim
mun
ity
Turk
etal.;
1998
Clinicalstu
dy
26patie
ntsin
hemod
ialysis
and11healthy
patie
nts(HP)
werev
accinated
with
multiv
alent
influ
enza
vaccine(MIV
)
Supp
lementatio
nwith
120m
gof
ZnSO
4
Znsupp
lementatio
ncouldno
tresto
retheimmun
eparam
etersa
ndenhancea
ntibod
yrespon
seto
MIV
inHP
Wierin
gaet
al.;2010
Rand
omized,
doub
le-blin
d,controlledtrial
229pregnant
wom
enwith
agesta
tionalage
<20
weeks,and
infantsa
ndwom
enwere
follo
wed
upmon
thlyun
tiltheinfantswere
6mon
thso
ld
Inadditio
nto
iron(30m
gas
ferrou
sfumarate)andfolic
acid
(0,4mg),one
grou
pof
wom
enreceived𝛽-c
arotene
(4,5mg),one
grou
pzinc
(30m
gas
zinc
sulfate),andon
egroup𝛽-c
arotenep
lus
zinc
(4,5and30
mg,resp.)
Maternalsup
plem
entatio
nwith
zinc
and𝛽-carotenea
ffected
the
newbo
rn’sim
mun
edevelo
pment,
buto
nlyzinc
supp
lementatio
naffectsmorbidityin
theinfants
Innate
immun
ityZinc
givesh
igherinterleuk
in-6
prod
uctio
n
Erickson
etal.;2000
Review
Hum
ans
Supp
lementatio
nsuch
aszinc,sele
nium
,iro
n,copp
er,b-carotene,vitaminsA
,C,
andE,
andfolic
acid
Micronu
trientsh
avea
nim
portant
rolein
immun
ityInnate
immun
ity
Zinc
enhances
naturalkiller
cell
functio
ns;
zinc
supp
lementatio
ndirectlyindu
ced
cytokine
prod
uctio
n,predom
inantly
IL-1,
IL-6,and
TNF-a,by
mon
onuclear
cells
invitro
Maggini
etal.;2007
Review
Hum
ans
Inadequateintake
andsta
tuso
fvitaminsa
ndtracee
lementsmay
lead
tosupp
ressed
immun
ity,w
hich
predisp
oses
toinfections
and
aggravates
undernutrition.
Therefore,supp
lementatio
nwith
theses
electedmicronu
trients
(inclu
ding
zinc)can
supp
ortthe
body’snaturald
efense
syste
mby
enhancingallthree
levelsof
immun
ity
Skin
innate
andadaptiv
eim
mun
ity
Itisinvolved
inthec
ytosolicdefense
againsto
xidativ
estre
ss(sup
eroxide
dism
utasea
ctivity
)and
isan
essential
cofactor
forthymulin
which
mod
ulates
cytokine
releasea
ndindu
ces
proliferatio
n.Ithelpstomaintainskin
andmucosalmem
braneintegrityand
increasesc
ellularc
ompo
nentso
finn
ate
immun
ity(e.g.,ph
agocytosisby
macroph
ages
andneutroph
ils,N
Kcell
activ
ity,generationof
oxidativeb
urst,
DTH
activ
ity),antib
odyrespon
ses,and
then
umbersof
cytotoxicC
D8þTcells
(Th1respo
nse)
-
10 Evidence-Based Complementary and Alternative MedicineTa
ble1:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityInvolved
Mechanism
ofactio
n
Calder
and
Kew;2002
Review
Increasin
gintakeso
fsom
enutrie
nts
aboveh
abitu
alandrecommended
levelscanenhances
omea
spectsof
immun
efun
ction;
lowplasmaZ
nlevelspredictedthes
ubsequ
ent
developm
ento
flow
errespira
tory
tractinfectio
ns
Skin
innateand
adaptiv
eim
mun
ity
Inpatie
ntsw
ithZn
deficiencyrelated
tosic
kle
celldisease,naturalkiller
cellactiv
ityis
decreased.
Zinc
supp
lementatio
nincreasesthymus
size,
andtopicalapp
licationof
Znim
proves
the
DTH
respon
sein
thea
reao
fskinon
which
the
applicationwas
made
Znadministratio
nto
preterm-lo
w-birth-weightinfantsincreasesthe
numbero
fcirc
ulatingTlymph
ocytes
andtheir
proliferatio
nanda5
mgZn
/dincreases
measureso
fcell-m
ediatedim
mun
efun
ction
Sing
hand
Das;2013
Review
Hum
ans
Thereisa
significantreductio
nin
the
duratio
nof
cold
atad
oseo
f≥75
mg/day
Zinc
administered
with
in24
hours
ofon
seto
fsym
ptom
sreduces
the
duratio
nof
common
cold
symptom
sinhealthypeop
le
Enhancem
ent
ofinnateas
wellas
acqu
ired
immun
ity
Not
clear
Hojyo
and
Fukada;2016
Review
Znhasroleindend
riticcells
(that
areimpo
rtanttopresentthe
peptide-MHC-
IIcomplex
ontheir
cellsurfa
ceto
antig
en-specific
CD4+
helper
T(Th
)cellsto
initiate
immun
erespo
nses)b
ecause
aredu
ctionin
Znisrequ
iredfor
prop
erantig
enpresentatio
nvia
MHC-
IIto
elicitadaptiv
eimmun
erespon
ses
Zndeficiencyischaracteriz
edby
immun
odeficiency
with
thym
icatroph
yandlymph
openia
Zncontrolsantib
ody-mediated
humoralim
mun
erespo
nses
and
ZIP10-Zn
hasa
rolein
early
B-cell
developm
entand
them
aintenance
ofmatureB
cells
ZIP10-Zn
signalin
gmay
controlfate
decisio
nsin
lymph
ocytep
rogenitors
underp
hysio
logicalcon
ditio
nsand
exacerbatemalignancyun
der
pathologicalcond
ition
s,according
totheh
ighlyregu
latedpatte
rnof
ZIP10expressio
n
Innateand
adaptiv
eim
mun
ity
Znfacilitates
thee
ndocytosisof
MHC-
IIbu
tinhibitsthetraffickingof
MHC-
IIfro
mthe
lysosome/endo
somec
ompartmentsto
the
plasmam
embrane
theZ
nD-in
ducedthym
icatroph
ycouldresult
from
thec
ombinatio
nof
increased
glucocortic
oidlevels,
anim
pairm
ento
fthym
ulin
activ
ity,and
impaire
dcell-intrinsic
survivalfunctio
nZIP10-Zn
signalin
gregulates
thee
xpressionof
CD45Rwhilesim
ultaneou
sly(and
indirectly)
enhancingtheC
D45RPT
Pase
activ
itythroug
haZ
n-depend
entp
rocessrather
than
byad
irect
effecto
nPT
Pase
activ
ityTh
eeffecton
developm
entcou
ldbe
explained
byglucocorticoids
andZIP10maintains
mature
Bcells
throug
haL
YN-in
depend
entm
echanism
ZIP10-Zn
signalin
ginhibitsthea
poptosis
indu
cedby
activ
ated
caspases
andprom
otes
pro-B-cellsurvivalin
acell-a
uton
omou
smanner
Cytokine
stim
ulation(th
efirstsignal)activ
ates
theJAK-
STAT
pathway
(thes
econ
dsig
nal),
which
furtherind
uces
ZIP10expressio
nand
eventuallygeneratesZ
IP10-Znsig
nals(th
ethird
signal)
-
Evidence-Based Complementary and Alternative Medicine 11
Records identified through database
[n = 152]
Records excluded [n = 48]
Reasons:(i) Not pertinent, n = 18
(ii) Other manuscript type, n = 27(iii) Duplicates, n =3
Records screened[n = 104]
Full-text articles assessed for eligibility[n = 104]
(i) Zinc = 35(ii) Vitamin D = 33
(iii) Vitamin C = 22(iv) Echinacea = 14
Studies included in the review[n = 82]
Identifi
catio
nScreening
Eligibility
Inclu
ded
Records excluded [n = 22]
Reasons:(i) Not pertinent, n = 11
(ii) Other manuscript type, n = 10(iii) Duplicates, n = 1
(i) Zinc = 28(ii) Vitamin D = 26
(iii) Vitamin C = 14(iv) Echinacea = 14Note. Some articles are included in all three topics.
(PUBMED) searching
Figure 1: Flow chart of the study selection process.
the inflammatory cytokine IL-1𝛼 and the anti-inflammatory product IL-1ra [43]. After zinc restric-tion, there was reduction in the in vitro secretion ofinterleukin-2 receptor (IL-2R) [44]. Zinc is involvedin the cytosolic defense against oxidative stress(superoxide dismutase activity) [10]. Recently, thetranscriptional repressor Gfi1, a zinc finger protein,was identified as a regulator of immune response[45]. Inflammatory cytokines, such as tumor necrosisfactor 𝛼 and interleukin (IL) 1, are also known togenerate greater amounts of reactive oxygen speciesand these parameters significantly decrease after zincsupplementation in the elderly (45mg) [46]. Zn couldnormalize the production of interleukins, such asIL-2 [9], but also IL-1, IL-6, and tumor necrosisfactor 𝛼 (TNF-a), by mononuclear cells in vitro [11].It modulates cytokine release by peripheral bloodnuclear cells [26]. Il-6 increased in infants born tomothers that received Zn supplementation [47]. Mostimportant, the ex vivo generation of TNF-𝛼 fromisolated mononuclear cells (MNCs) is significantlydecreased in elderly subjects after zinc supplemen-tation [46]. Finally, Zn has role in the productionof interferon-𝛾 [48]. Zinc is involved also in thebiosynthesis of leukotriene B4, which is implicated in
a variety of acute and chronic inflammation, includ-ing chronic-obstructive pulmonary disease (COPD)[45]. The antiviral effects of zinc (5mg), through theIntercellular Adhesion Molecule 1 (ICAM-1) receptorblocking, have been considered as one of the mostimportant actions for impacting on incidence and/orduration of upper respiratory tract infections (URTI)[49].
3.1.3. Third Barrier: Adaptive Immunity. Zn is required forproper antigen presentation via MHC-II to elicit adaptiveimmune responses [35]. Zinc deficiency in experimentalanimals is associated with low thymic weight and pro-gressive loss of T lymphocytes (T cells) because zinc isan essential cofactor for the thymic hormone thymulin.Thymulin induces several T cell markers and promotes T cellfunction, including allogenic cytotoxicity, suppressor func-tions, and interleukin-2 production [26]. Zn supplementation(30mg/day) is required in order to enhance functions of Tcells, thanks to an increase in the production of T cells and/ora decrease in the loss of T cell precursors via apoptosis [50].It increases the number of CD4 (helper) lymphocytes in chil-dren with a 10–20mg of supplementation [36] or with 5mg ofzinc [51] and also CD8 [9, 26]. Since it is an essential cofactor
-
12 Evidence-Based Complementary and Alternative Medicine
for thymulin [10], a possible explanation of these effects onT cells is related to thymulin levels, which is required for thedifferentiation of CD4+ T cells [45, 52]. Another explanationis a direct effect of zinc ion on the lymphocyte membraneaffecting maturation and differentiation of T lymphocytes[37]. Zinc acts on T lymphocytes through modulating IL-2 secretion, receptor expression, and sensitivity [45]. Zncontrols antibody-mediated humoral immune responses, anda zinc cell-membrane-localized transporter (ZIP10-Zn) hasa role in early B-cell development and the maintenance ofmature B cells [35].
3.1.4. Zinc Supplementation for Common Colds. Many stud-ies have agreed that supplementation of zinc is helpful inreducing the risk of pneumonia and common cold and theincidence of respiratory tract infection, specifically in theelderly and in children [9, 33, 36, 50, 53, 54]. Zinc sup-plementation (20mg/day) accelerates recovery from severepneumonia in children [42]. (However, two articles werefound which do not support a role for intranasal zinc(gluconate) in prevention or treatment of the common coldor immune parameters [55, 56], but in these two studies theway of administration is intranasal.) Very recently two meta-analyses demonstrated that zinc may shorten the duration ofcolds by approximately 33% [57]. However, there are sometopics about zinc and common cold that are still not clear.In particular, high dosage of zinc in clinical trials has causedadverse effects, such as bad taste, and the variation in the totaldaily dose of zinc.
In conclusion, given the discreet evidence of efficacyon shortening the duration of colds by approximately 33%,common cold patientsmay be instructed to try zinc within 24hours of onset of symptoms [57]. However, since controlledtrials that have examined the effect of zinc on the commoncold have diverged, the optimal composition and dosage ofzinc should be better investigated in addition to the optimumfrequency of their administration.
3.2. Vitamin D and Three Main Immune Interactive Clusters(Physical Barriers, Innate and Adaptive Immunity) Involvedduring an Episode of Common Colds. This research has beencarried out based on the following keywords: “vitamin D”OR “vitamin D supplementation” AND “immune response”AND “innate immunity” AND “adaptive immunity” AND“respiratory tract infections” AND “common cold” AND“immunodeficiency.”
Figure 1 shows the study selection process.Table 2 summarizes the studies presented in the narrative
review.
3.2.1. First Barrier: Physical Barrier. The active hormone1,25(OH)2D is important in upregulating genes via the 1a-hydroxylase enzyme, which then encode proteins requiredfor tight junctions (e.g., occludin), gap junctions, andadherens junctions (e.g., E-cadherin) [58].
Vitamin D supplementation increases cathelicidin pro-duction and it is involved in the production of defensins [59].
These antimicrobial peptides are also involved in the secondbarrier.
3.2.2. Second Barrier: Cellular Natural Immunity. A review byHewison et al. shows that vitamin D supplementation is suc-cessful in raising serum levels of 25OHD in TB patients and itmay also play a role in promoting innate immune responsesto enhance monocyte phagocytosis and degradation of b-amyloid.
The effects of vitamin D3 on macrophage phagocyto-sis may be related to the ability of that vitamin to altermonocyte maturation. Thus, D3 enhances immunoglobulinand complement-mediated phagocytosis by human mono-cytes through its stimulation of monocyte maturation tomacrophages [11].
Enhancing protective innate immune responses,1,25(OH)2D helps maintain self-tolerance by dampeningoverly zealous adaptive immune responses.
In addition, oral supplementation with HyD (25(OH)D3metabolite) at a dose of 20𝜇g per day may explain the benefitof HyD on systolic blood pressure reduction, improvementin lower extremity function, and the more pronouncedreduction in several markers of innate immunity amonghealthy postmenopausal women [60].
3.2.3. Third Barrier: Adaptive Immunity. Human epidemio-logical studies indicate supplementation with 1,25(OH)2D3as an independent protective factor influencing the occur-rence of Th-1 mediated autoimmunity [10]. The effectsof 1,25(OH)2D on the immune system include decreasingTh1/Th17 CD4+ T cells and cytokines, increasing regulatoryT cells, downregulation of T cell-driven IgG production, andinhibition of dendritic cell differentiation [61]. The adaptiveimmune effects of vitamin D are not restricted to effector Tcells and also include actions on suppressor or regulatory Tcells (Treg), a group of CD4+ T cells known for inhibiting theproliferation of other CD4+T cells. Treatment of naive CD4+T cells with 1,25(OH)2D potently induces the developmentof Treg, and this may exert beneficial effects in autoimmunedisease and host-graft rejection [62].
A short term high-dose vitD3 supplementation(140.000 IU) significantly increased the frequency ofregulatory T cells (Tregs) but did not further improve 𝛽-cellfunction in apparently healthy subjects.
VitD3 may be a useful therapeutic agent in autoimmunediseases exerting immunemodulatory effects involving stim-ulatory actions on Tregs [63].
Vitamin D deficiency or insufficiency has immuno-logical implications in patients with recurrent miscarriage(RM). The percentage of B cells, the percentage of TNF-𝛼-producing Th cells, and NK cytotoxicity are significantlyreduced under 0.5 𝜇g/day of 1,25(OH)2D supplementationfor 2 months [64]. Treatment with 4000 IU vitamin D3 sig-nificantly reduced CD4+ T cell activation compared to low-dose vitamin D3, providing human evidence that vitamin Dcan influence cell-mediated immunity [65].
Vitamin D associated with upper respiratory tract infec-tions (URI) burden probably involves lymphocytes and their
-
Evidence-Based Complementary and Alternative Medicine 13
Table2:Stud
ieso
nvitamin
D,immun
ity,and
common
cold
presentedin
then
arrativ
ereview.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Bergman
etal.;
2015
Arand
omized,
placebo-
controlled,and
doub
le-blin
ded
study
Thep
erprotocol
popu
latio
n(𝑛=124
patie
ntsa
ged18
to75
years),w
hocompleted
thes
tudy,con
sistedof
𝑛=62
vitamin
Dtre
ated
and𝑛=62
placebo
treated
patie
nts.
𝑛=62
oralvitamin
D3
(400
0IU/day
for1
year)
treated
and𝑛=62
oil
(Miglyol)p
lacebo
treated
patie
nts.
Follo
w-up:12
mon
ths.
Vitamin
Dsupp
lementatio
nincreasedthe
prob
abilityof
staying
freeo
frespiratory
tract
infections
(RTI)d
uringthes
tudy
year
(RR
0.64
,95%
CI0.43–0
.94).Further,the
total
numbero
fRTIsw
asalso
redu
cedin
the
vitamin
Dgrou
p(86R
TIs)versus
placebo
(120
RTIs;𝑝=0.05).Finally,the
timetothe
firstRT
Iwas
significantly
extend
edin
the
vitamin
Dgrou
p(H
R1.6
8,95%CI
1.03–2.68,
𝑝=0.0376).
Ther
oleo
fvitamin
Din
respira
tory
tractinfectio
nsisstillno
tclear,despite
severallarge
RCTs
inthe
area.Th
iscanprob
ablybe
explainedby
thelarge
heterogeneity
inthese
rand
omized
controlled
trials(RCT
s).
Bock
etal.;2011
Ado
uble-blin
d,placebo-
controlled
trial
59healthyadultsub
jects
(49%
females).
Subjectsreceived
oral
vitD
3(14
0,00
0IU
oleovitD
3,mon
thly)o
rplacebo(alm
ondoil)for
aperiodof
3mon
ths.
%regu
latory
Tcells
(Tregs)increased
significantly
onlyin
thev
itDgrou
p.Ashort
timeh
igh-do
sevitD
3supp
lementatio
nsig
nificantly
increasedthefrequ
ency
ofTregs,
butd
idno
tfurther
improve𝛽
-cellfun
ctionin
apparentlyhealthysubjects.
Adaptiv
eim
mun
ity:T
cells
and𝛽cellfunctio
n
Theimmun
omod
ulatory
potentialofvitDmight
bean
impo
rtantm
echanistic
linkforthe
associationof
vitD
andT1D.
Goo
dalletal.;
2014
Dou
ble-blind
clinicaltria
l
600participants(≥17
years),471
(78.5%
)completed
allsurveys
while43
(7.2%
)completed
none.
Participantswere
rand
omized
toreceivea
containerw
itheight
capsules
ofeither
10,000
IUof
activ
evitamin
D3or
identic
alplacebo.Stud
entsare
rand
omized
into
4tre
atmentarm
s:(1)
vitamin
D3andgarglin
g,(2)p
lacebo
andgarglin
g,(3)v
itamin
D3andno
garglin
g,and(4)p
lacebo
andno
garglin
g.
Of6
00participants,
471(78.5%)com
pleted
all
surveysw
hile43
(7.2%
)com
pleted
none;150
(25.0%
)reportedclinicalU
RTI.Seventy
participants(23.3%
)rando
mized
tovitamin
D3
repo
rted
clinicalU
RTIcom
paredto
80(26.7%
)rand
omized
toplacebo(RR:
0.79,C
I95:
0.61–1.03,𝑝=0.09).Eighty-five
participants
(28.3%
)rando
mized
togarglin
grepo
rted
clinicalupp
errespira
tory
tractinfectio
n(U
RTI)comparedto
65participants(21.7
%)
rand
omized
tothen
ogarglin
garm
(RR:
1.3,
CI95:0.92–1.5
7,𝑝=0.19).Labo
ratory
testing
identifi
ed70
infections
(46.7per100
URT
Is).
Vitamin
D3tre
atmentw
asassociated
with
asig
nificantly
lower
riskforlaboratory
confi
rmed
URT
I(RR
:0.54,CI
95:0.34–
0.84,
𝑝=0.007)
andwith
asignificantly
lower
mean
viralloadmeasuredas
log10viralcop
ies/mL
(meandifference:−0.89,C
I95:−1.7,−
0.06,
𝑝=0.04).Fewer
studentsa
ssignedto
garglin
gexperie
nced
labo
ratory
confi
rmed
URT
I;ho
wever
thiswas
notstatisticallysig
nificant
(RR:
0.82,C
I95:0.53–1.26,𝑝=0.36).
Vitamin
D3isap
romising
interventio
nforthe
preventio
nof
URT
I.Vitamin
D3sig
nificantly
redu
cedther
iskof
labo
ratory
confi
rmed
URT
Iandmay
redu
cether
iskof
clinicalinfectio
ns.
-
14 Evidence-Based Complementary and Alternative Medicine
Table2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Camargo
etal.;
2012
Dou
ble-blind
clinicaltria
l
744Mon
golian
child
renfro
m21
third
-andfourth-grade
classroom
s(9-10
years
old),but
thisanalysis
focusedon
asub
seto
f247child
renwho
were
assig
nedto
daily
ingestionof
unfortified
regu
larm
ilkor
milk
fortified
with
300I
Uof
vitamin
D3.
50%of
child
ren,
who
drankmilk
,werem
ale.
54%of
child
ren,
who
drankmilk
vitamin
Dfortified
werem
ale.
TheB
lueS
kyStud
yexam
ined
5approaches
toim
provethe
vitamin
Dsta
tuso
fMon
golian
scho
olchild
ren:
(1)3
00IU
ofvitamin
D3
daily
inMon
golianmilk
(𝑛=143);(2)
300I
Uof
vitamin
D3daily
inUS
milk
(𝑛=143);(3)
300I
Uof
vitamin
D3
daily
inam
ilksubstitute
(𝑛=147);(4)
300I
Uof
vitamin
D3in
adailypill
(𝑛=112);and
(5)a
total
of13,700
IUof
vitamin
D3in
pills
givenover
the
first7days
ofstu
dy(𝑛=95).
Follo
w-up:winter
(Janu
ary–March).
Atbaselin
e,them
edianserum
25(O
H)D
level
was
7ng/mL(in
terquartile
range:5–10ng
/mL).
Atthee
ndof
thetria
l,follo
w-upwas
99%
(𝑛=244),and
them
edian25(O
H)D
levelsof
child
renin
thec
ontro
lversusv
itamin
Dgrou
psweres
ignificantly
different
(7versus
19ng
/mL;
𝑝=0.001).C
omparedwith
controls,
child
ren
receivingvitamin
Drepo
rted
significantly
fewer
ARIsd
uringthes
tudy
perio
d(m
ean:
0.80
versus
0.45;𝑝=0.047),w
ithar
ater
atio
of0.52
(95%
confi
denceinterval:0.31–0
.89).
Adjustingfora
ge,gender,andhisto
ryof
wheezing,vitamin
Dcontinuedto
halvethe
riskof
ARI
(rater
atio:0.50[95%
confi
dence
interval:0.28–0.88]).Sim
ilarresultswere
foun
dam
ongchild
reneither
belowor
above
them
edian25(O
H)D
levelatb
aseline
(rate
ratio
:0.41v
ersus0
.57;pforinteractio
n=.27).
Vitamin
Dsupp
lementatio
nsig
nificantly
redu
cedthe
riskof
ARIsinwinter
amon
gMon
golianchild
ren
with
vitamin
Ddeficiency.
Urashim
aetal.;
2010
Amultic
enter,
rand
omized,
doub
le-blin
d,placebo-
controlled,
parallel-g
roup
trial
430scho
olchild
ren(56%
werem
ale)aged
6–15y,
with
orwith
out
underly
ingdiseases,
weree
ligibleandasked
toparticipateinthe
study
bythe
pediatric
ians
incharge
oftheo
utpatie
ntclinics.
Thep
articipantswere
askedto
take
3tablets
twiced
aily,
total:1200
IUvitamin
D3(217
child
ren)
orplacebo(213
child
ren).
Thea
ccrualperio
dwas
from
Decem
ber1,2008,
toMarch
31,200
9.
Influ
enza
Aoccurred
in18
of167(10.8%
)child
renin
thev
itamin
D3grou
pcompared
with
31of
167(18.6%
)childrenin
thep
lacebo
grou
p[rela
tiver
isk(RR),0.58;95%CI
:0.34,
0.99;𝑝=0.04].Th
ereductio
nin
influ
enza
Awas
morep
rominentinchild
renwho
hadno
tbeen
taking
otherv
itamin
Dsupp
lements(RR:
0.36;95%
CI:0.17,0.79;𝑝=0.006)
andwho
startednu
rseryscho
olaft
erage3
y(RR:
0.36;
95%CI
:0.17,0.78;𝑝=0.005).Inchild
renwith
apreviou
sdiagn
osisof
asthma,asthmaa
ttacks
asas
econ
dary
outcom
eoccurredin
2child
ren
receivingvitamin
D3comparedwith
12child
renreceivingplacebo(RR:
0.17;95%
CI:
0.04,0.73;𝑝=0.006).
Vitamin
D3
supp
lementatio
ndu
ringthe
winterm
ayredu
cethe
incidenceo
finfl
uenzaA
,especiallyin
specific
subgroup
sof
scho
olchild
ren.
-
Evidence-Based Complementary and Alternative Medicine 15
Table2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Şişm
anlare
tal.;
2016
Clinicaltrial
Sixty-threec
hildren
aged
betweensix
mon
ths
andfivey
earswith
lower
respira
tory
infections
and59
age-matched
child
renwho
hadno
histo
ryof
respira
tory
symptom
sinthelast
mon
thandno
accompanyingchronic
disease.
Follo
w-up:Decem
ber
2010
andFebruary
2011.
25(O
H)v
itamin
Dlevel
of<20
ng/m
Lwas
considered
vitamin
Ddeficiency,alevelof
20–30n
g/mLwas
considered
vitamin
Dinsufficiency,a
levelof
>30
ng/m
Lwas
considered
norm
al,and
alevelof
>150–
200n
g/mLwas
considered
intoxicatio
n.
Nosig
nificantcorrelationwas
foun
dbetween
vitamin
Dlevelsandlower
respira
tory
tract
infectionin
term
sofd
iseasea
ndits
severity.
How
ever,itw
asfoun
dthatvitamin
Ddeficiency/insufficiency
was
observed
with
ahigh
ratein
allchildreninclu
dedin
thes
tudy.
Alth
ough
nocorrelation
was
foun
dbetweenvitamin
Dleveland
lower
respira
tory
tractinfectio
n,itisrecommendedthat
vitamin
Dlevelsho
uldbe
measuredin
child
renwith
lower
respira
tory
tract
infectionandvitamin
Dsupp
lementatio
nshou
ldbe
givento
allchildren
especiallyin
winterm
onths
basedon
thefactthatthe
levelofvitamin
Dwas
lower
than
norm
alin
approxim
ately
halfof
the
child
reninclu
dedin
the
study
andconsideringthe
effectsof
vitamin
Don
infections,pulmon
ary
functio
ns,and
immun
ity.
Li-ngetal.;2009
A3-mon
thprospective,
rand
omized,
doub
le-blin
d,placebo-
controlledtrial
ofvitamin
D3
supp
lementa-
tionin
ambu
latory
adults
162adults(18–80
years
old)
werer
ando
mized.
Male:17
activ
e,13
placebo.
Female:61
activ
e,57
placebo.
84patie
ntsreceived
50𝜇g/dvitamin
D3and
78patie
ntsreceived
placebo.
Follow-up:March–Jun
e2007.
Therew
eren
osig
nificantd
ifferencesb
etween
thea
ctivea
ndplacebopatie
ntsa
tbaseline.Th
ebaselin
e25-OHDlevelsranged
from
16to
156n
mol/lwith
meanlevelof63.7±28.7nm
ol/l
inthes
tudy
popu
lation.
Atbaselin
e,23%of
the
activ
epatientse
xceeded75
nmol/l.
-
16 Evidence-Based Complementary and Alternative Medicine
Table2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Bischo
ff-Ferrariet
al.;2012
Clinicaltrial
20white
postm
enop
ausalw
omen,
50to
70yearso
fage,in
generalgoo
dhealth
with
anaverage2
5(OH)D
levelof13.2±3.9ng
/mL
(mean±SD
)and
amean
ageo
f61.5±7.2years
werer
ando
mized
toeither
20mgof
HyD
or20
mg(800
IU)o
fvitamin
D3perd
ayin
ado
uble-blin
dmanner.
Participantsattend
edon
escreening
visit
and
14clinicalvisitsdu
ringa
4-mon
thtrialp
eriod.
Wom
enwho
passed
eligibilitycriteria
signed
inform
edconsentand
werer
ando
mlyassig
ned
toon
eoffou
rgroup
s:20
mgHyD
daily,20m
g(800
IU)v
itamin
D3
daily,140
mgHyD
weekly,or
140m
g(560
0IU)v
itamin
D3
weekly.Allsupp
lements
weretaken
orally.
We
rand
omized
five
participantsto
each
treatmentg
roup
.The
dose
ofvitamin
D3was
chosen
tocompare
tothec
urrent
stand
ardfor
vitamin
D3
(20m
g(1/4)800I
U/d).
Mean25(O
H)D
levelsincreasedto
69.5ng
/mL
intheH
yDgrou
p.Th
isris
ewas
immediateand
susta
ined.M
ean25(O
H)D
levelsincreasedto
31.0ng
/mLwith
aslowincrease
inthev
itamin
D3grou
p.Wom
enon
HyD
comparedwith
vitamin
D3had2.8-fold
increasedod
dsof
maintainedor
improved
lower
extre
mity
functio
n(odd
sratio
[OR](1/4)2.79;95%
confi
denceinterval[CI
],1.18–6.58)a
nda
5.7-mmHgdecrease
insysto
licbloo
dpressure
(𝑝(1/4)0.0002).B
othtypeso
fvitamin
Dcontrib
uted
toad
ecreaseinfiveo
utof
seven
markersof
innateim
mun
ity,significantly
more
pron
ounced
with
HyD
fore
otaxin,IL-12,
MCP
-1,and
MIP-1b.Th
erew
eren
ocaseso
fhypercalcemiaatanytim
epoint.Twenty
microgram
s(20
mg)
ofHyD
perd
ayresultedin
asafe,im
mediate,and
susta
ined
increase
in25(O
H)D
serum
levelsin
allp
artic
ipants,
which
may
explainits
significantb
enefito
nlower
extre
mity
functio
n,systo
licbloo
dpressure,and
innateim
mun
erespo
nse
comparedwith
vitamin
D3.
innateim
mun
erespon
se
Thes
tudy
show
sthat2
0mg
HyD
issig
nificantly
more
efficientand
morer
apid
inshiftinghealthy
postm
enop
ausalw
omen
into
adesira
ble2
5(OH)D
serum
levelofatleast
30ng
/mLcomparedto
800I
U(20m
g)vitamin
D3.
Charan
etal.;2012
Asyste
matic
review
and
meta-analysis
Hum
ans
Adults(18–80
year,
18–28men,and
postm
enop
ausal
wom
en)a
ndchild
ren
(1–3
year,6–15year).
Thep
opulationnu
mber
isno
treported.
Doseo
fvitamin
Dused
inthesec
linicaltrials
ranged
from
400I
U/day
to2000
IU/day.Inon
eclinicaltria
lsingle
parenteraldo
seof
vitamin
Dwas
given
(100
000I
U).
Eventsof
respira
tory
tractinfectio
nswere
significantly
lower
invitamin
Dgrou
pas
comparedto
controlgroup
[odd
sratio
=0.582
(0.417–0
.812)𝑝=0.001]
accordingto
rand
ommod
el.Onseparateanalysisof
clinicaltria
lsdealingwith
grou
psof
child
renandadults,
beneficialeffectof
vitamin
Dwas
observed
inbo
th,according
tofixed
mod
el[odd
sratio
=0.579(0.416–0
.805),𝑝=0.001andod
dratio
=0.653(0.472–0
.904
0),𝑝=0.010resp.].
Innateand
adaptiv
eim
mun
ity
Itisbelievedthatvitamin
Dincreasesthe
prod
uctio
nof
naturalantibod
ies.Vitamin
Disalso
know
nto
streng
then
theimmun
ityby
indu
cing
mon
ocyte
differentiatio
nand
inhibitin
glymph
ocyte
proliferatio
n.Itisalso
postu
latedthatvitamin
Denhances
thep
hagocytic
activ
ityof
macroph
ages.
-
Evidence-Based Complementary and Alternative Medicine 17
Table2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Chen
etal.;2016
Clinicaltrial
99wom
enwith
ahistory
oftwoor
more
successiv
emisc
arria
ges.
Atotalof35patie
nts
constituted
thev
itamin
Dno
rmalgrou
p(V
DN)
(age
33.6y±3.9),and
51patie
ntsw
ereincludedin
thev
itamin
Dinsufficiency
grou
p(V
DI)(age
32.4y±3.9),
and13
vitamin
Ddeficiencypatie
ntsin
VDD(age
33.0y±4.4).
Patie
ntsw
ithrecurrent
misc
arria
ge(RM)w
ere
supp
lementedwith
0.5𝜇
g/dayof
1,25(OH)2Dfor2
mon
thsa
ndthen
perip
heralblood
cells.
Thep
ercentageo
fCD19+Bcells
andNK
cytotoxicityatan
effector-to-ta
rgetcell(E
:T)
ratio
of50
:1,25:
1,and12.5:1weresignificantly
high
erin
thev
itamin
Dinsufficiency
grou
p(V
DI)than
inthev
itamin
Dno
rmalgrou
p(V
DN)(𝑝<.05each).Th
epropo
rtionof
TNF-𝛼-expressingTh
cells
was
significantly
high
erin
thev
itamin
Ddeficiencygrou
p(V
DD)thanin
VDN(𝑝<.05).H
owever,there
weren
osig
nificantd
ifferencesb
etweenVDI
andVDD.Th
isdysregulationwas
significantly
redu
cedwith
1,25(OH)2Dsupp
lementatio
n.
Innateand
adaptiv
eim
mun
ity:
cell-mediated
immun
ity
Itwas
foun
dthatthe
percentage
ofperip
heral
bloo
dCD
19+Bcells,the
percentage
ofTN
F-𝛼-
prod
ucingTh
cells,and
NK
cytotoxicityatallE
:Tratio
swered
ramatically
redu
cedun
der1,25(OH)2D
supp
lementatio
n.ithas
been
show
nthat
1,25(OH)2Dcould
downregulates
everalgenes
associated
with
TNF-𝛼,
inclu
ding
proteins
involved
inthetranscriptio
nof
TNF-𝛼,one
ofits
prim
ary
receptors,andTN
F-𝛼itself.
Vitamin
Dwas
also
ableto
depo
lariz
eperforin
expressio
nin
the
cytoplasm,w
hich
redu
ced
theN
Kcytotoxicityin
RMpatie
nts.
Dankersetal.;
2017
Review
Ther
eviewdiscussedthee
ffectof
vitamin
Dwhich
isthem
odulationof
theimmun
esystem.
Ther
eviewdiscussesthe
currentk
nowledge
abou
tthe
molecular
mechanism
sund
erlying
theimmun
omod
ulatoryeffectsof
vitamin
Dandho
wthesea
dvancesc
anbe
used
inthe
treatmento
fautoimmun
edise
ases.
Autoim
mun
ity,
innateandadaptiv
eim
mun
ity
-
18 Evidence-Based Complementary and Alternative Medicine
Table2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
DeG
ruijland
Pavel;2012
Rand
omized
clinicalstudy
105stu
dent
volunteers
(18–30
yearso
fage)
divide
in3grou
ps.
Thep
articipantswere
rand
omized
to3grou
ps:
(A)sub
jected
to3tim
esaw
eeksub-sunb
urn
sunb
edexpo
sure
(𝑛=35),(B)d
aily
vitamin
Dsupp
lementatio
n,1000
IU(𝑛=37),and
(C)a
controlgroup
with
outany
interventio
n(𝑛=33).Th
emean
serum
levelof
25-hydroxy
vitamin
D(25(OH)D
)dropp
edfro
m62
to55
nmoll−1
ingrou
pC,
whilethese
levelsrose
from
62to
109
andfro
m58
to93
nmol
l−1in
grou
psAandB.
Alth
ough
fewer
coldso
ccurredin
theg
roup
s(A
)and
(B)com
paredwith
controlgroup
(C),
thed
ifference
was
notsignificant.Th
einitia
l25(O
H)D
levelsin
thev
olun
teersthatcaughta
cold
(𝑛=61)w
eren
otsig
nificantly
different
from
thosew
hodidno
t(𝑛=44):meanof
61(SD21)v
ersus6
1(SD
20)n
moll−1
(nor
were
thefi
nallevelsd
ifferent:meanof
86(SD31)
versus
86(SD32)n
moll−1
).
Innateim
mun
ityandskin
barrier
Thes
tudy
show
ssub-sunb
urnsunb
edtre
atmenttobe
effectiv
ein
tann
ingandin
increasin
gthe2
5(OH)D
serum
level,
mores
othan
oralvitamin
Dsupp
lementatio
nby
1000
IUperd
ay.D
espite
earlier
results
suggestin
ga
possiblebeneficialeffecton
colds,this8-week
mid-w
interc
ourseo
fsunb
edexpo
suresh
as,
however,noappreciable
effecto
ncolds.
deSá
DelFiolet
al.;2015
Review
Hum
ans.
Thisstu
dyaimed
toreview
recent
clinicaland
epidem
iologicalstudies
cond
uctedin
adults
andchild
renandto
evaluatethefun
ctionalrole
ofvitamin
Din
respira
tory
infections.Th
eevaluatedstu
dies
show
anim
portant
immun
omod
ulatoryroleof
vitamin
D,w
hich
redu
cesthe
incidencea
ndris
kof
URT
Is(upp
errespira
tory
tractinfectio
ns),bo
thin
child
ren
andin
adults.
Com
batin
gURT
Iscanbe
done
prop
hylactically,
associatingtheu
seof
vaccines
againstStre
ptococcusp
neum
oniaew
ithstreng
theningtheimmun
esystem
throug
hsupp
lementatio
nwith
vitamin
D.
Innateand
adaptiv
eimmun
esyste
m
Vitamin
Dappearsto
combatinfectio
nvia
multip
lemechanism
s.It
hasa
directinflu
ence
onthep
rodu
ctionof
cathelicidin,w
hich
may
lead
toincreased
susceptib
ilityto
virusesa
ndbacteria,and
itinflu
ences
cytokine
profi
lesd
uring
infectionviathe
innateand
adaptiv
eimmun
esystem.
-
Evidence-Based Complementary and Alternative Medicine 19Ta
ble2:Con
tinued.
Authors
Type
ofstu
dySubjects
Dosage
Results
Type
ofim
mun
ityinvolved
Mechanism
ofactio
n
Denlin
gere
tal.;
2016
Aclinicaltria
l:theA
sthm
aNet
VID
A(V
itamin
DAd
d-on
Therapy
Enhances
Corticosteroid
Respon
siveness)
trial
408adult
patie
nts.
Patie
ntsa
rerand
omized
toreceivep
lacebo
orcholecalciferol
(100,000
IUload
plus
4,00
0IU/d)for
28weeks
asadd-on
therapy.
Atotalof203
participantsexperie
nced
atleasto
necold.
Despiteachieving25-hydroxy
vitamin
Dlevelsof
41.9ng
/ml(95%confi
denceinterval[CI
],40
.1–43.7ng
/ml)by
12weeks,vitamin
Dsupp
lementatio
nhadno
effecto
nthep
rimaryou
tcom
e:thea
verage
peak
WURS
S-21
scores
(62.0[95%
CI,
55.1–
68.9;placebo
]and
58.7[95%
CI,52.4–
65.0;vitamin
D];𝑝=0.39).Th
erateo
fcolds
didno
tdiffer
between
grou
ps(rater
atio
[RR],1.2